Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475–482

Article  PubMed  Google Scholar 

Olafsson E, Ludvigsson P, Gudmundsson G, Hesdorffer D, Kjartansson O, Hauser WA (2005) Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol 4:627–634

Article  PubMed  Google Scholar 

Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R (2007) How common are the “common” neurologic disorders? Neurology 68:326–337

Article  CAS  PubMed  Google Scholar 

Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE et al (2017) Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia 58:522–530

Article  PubMed  Google Scholar 

Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L et al (2017) ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia 58:512–521

Article  PubMed  PubMed Central  Google Scholar 

Lüders H, Vaca GF, Akamatsu N, Amina S, Arzimanoglou A, Baumgartner C (2019) Classification of paroxysmal events and the four-dimensional epilepsy classification system. Epileptic Disord 21:1–29

Article  PubMed  Google Scholar 

Holtkamp M, Knake S, Pataraia E, Feichtinger M, Tettenborn B, Imbach L (2023) Neue Terminologie: anfallssuppressives Medikament/ Anfallssuppressivum. Clin Epileptol 36:81–82

Article  Google Scholar 

Mula M, Kanner AM, Jette N, Sander JW (2021) Psychiatric comorbidities in people with epilepsy. Neurol Clin Pract 11:112–120

Article  Google Scholar 

Elger CE, Helmstaedter C, Kurthen M (2004) Chronic epilepsy and cognition. Lancet Neurol 3:663–672

Article  PubMed  Google Scholar 

Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA (2012) Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol 72:184–191

Article  PubMed  Google Scholar 

Beghi E, Giussani G, Abd-Allah F, Abdela J, Abdelalim A, Abraha HN et al (2019) Global, regional and national burden of epilepsy, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 18:357–375

Article  Google Scholar 

Willems LM, Kondziela JM, Knake S, Schulz J, Neif B, Schade B et al (2019) Counseling and social work for people with epilepsy in Germany: a cross-sectional multicenter study on demand, frequent content, patient satisfaction and burden-of-disease. Epilepsy Behav 92:114–120

Article  PubMed  Google Scholar 

Thorbecke R, Pfäfflin M (2012) Social aspects of epilepsy and rehabilitation. Handb Clin Neurol 108:983–999

Article  PubMed  Google Scholar 

Fraser RT, Johnson EK, Lashley S, Barber J, Chaytor N, Miller JW et al (2015) PACES in epilepsy: results of a self-management randomized controlled trial. Epilepsia 56:1264–1274

Article  PubMed  Google Scholar 

Schwab C, Wadle N‑E, Knake S, von Podewils F, Siebenbrodt K, Kohlhase K et al (2021) Patients knowledge about epilepsy-related risks, morbidity and mortality: a multicenter cohort study from Germany. Epilepsy Behav 124:108343

Article  PubMed  Google Scholar 

Ried S, Specht U, Thorbecke R, Goecke Wohlfarth KR (2001) MOSES: an educational program for patients with epilepsy and their relatives. Epilepsia 42:76–80

Article  PubMed  Google Scholar 

Aybek S, Perez DL (2022) Diagnosis and management of functional neurological disorder. BMJ 376:o64

Article  PubMed  Google Scholar 

Beghi E, Carpio A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW et al (2010) Recommendation for a definition of acute symptomatic seizure. Epilepsia 51:671–675

Article  PubMed  Google Scholar 

Hesdorffer DC, Benn EK, Cascino GD, Hauser WA (2009) Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia 50:1.102–1.108

Article  Google Scholar 

Lutz MT, Helmstaedter C (2005) EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy. Epilepsy Behav 7:708–714

Article  CAS  PubMed  Google Scholar 

Fliessbach K, Hoppe C, Schlegel U, Elger CE, Helmstaedter C (2006) NeuroCogFX – eine computergestützte neuropsychologische Testbatterie für Verlaufsuntersuchungen bei neurologischen Erkrankungen. Fortschr Neurol Psychiatr 74:643–650

Article  CAS  PubMed  Google Scholar 

Metternich B, Wagner K, Buschmann F, Anger R, Schulze-Bonhage A (2012) Validation of a German version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav 25:485–488

Article  PubMed  Google Scholar 

Brandt C, Labudda K, Illies D, Schöndienst M, May TW (2014) Schnelle Erkennung einer depressiven Störung bei Menschen mit Epilepsie – Validierung einer deutschsprachigen Version des NDDI‑E. Nervenarzt 85:1.151–1.155

Article  Google Scholar 

Mula M, McGonigal A, Micoulaud-Franchi JA, May TW, Labudda K, Brandt C (2016) Validation of rapid suicidality screening in epilepsy using the NDDIE. Epilepsia 57:949–955

Article  PubMed  Google Scholar 

Hautzinger M, Keller F, Kühner C (2009) BDI-II. Beck-Depressions-Inventar. Revision, 2. Aufl. Pearson Assessment, Frankfurt

Google Scholar 

Micoulaud-Franchi JA, Lagarde S, Barkate G, Dufournet B, Besancon C, Trébuchon-Da Fonseca A et al (2016) Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD‑7 as a complementary tool to the NDDI‑E in a French sample. Epilepsy Behav 57:211–216

Article  PubMed  Google Scholar 

Michaelis R, Schlömer S, Popkirov S, Krämer G, Lindemann A, Cosentino M et al (2022) German translation and validation of the brief epilepsy anxiety survey instrument (brEASI). Epilepsy Behav 134:108857

Article  PubMed  Google Scholar 

Herrmann-Lingen C, Buss U, Snaith RP (2010) Hospital Anxiety and Depression Scale – Deutsche Version. Hogrefe Verlag

Google Scholar 

Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW et al (2007a) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369:1.000–1.015

Article  Google Scholar 

Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G et al (2021a) The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 397:1363–1374

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW et al (2007b) The SANAD study of effectiveness of valproate, lamotrigine or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369:1.016–1.026

Article  Google Scholar 

Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G et al (2021b) The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 397:1.375–1.386

Article  Google Scholar 

Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E et al (2018) Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 17:530–538

Article  CAS  PubMed  Google Scholar 

Bjork MH, Zoega H, Leinonen MK, Cohen JM, Dreier JW, Furu K et al (2022) Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability. JAMA Neurol 79:672–681

Article  PubMed  Google Scholar 

Elger CE, Berkenfeld R et al S1-Leitlinie Erster epileptischer Anfall und Epilepsien im Erwachsenenalter. 2017. In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. www.dgn.org/leitlinien. Zugegriffen: 22. Dez. 2023

Vegrim HM, Dreier JW, Alvestad S, Gilhus NE, Gissler M, Igland J et al (2022) Cancer risk in children of mothers with epilepsy and high-dose folic acid use during pregnancy. JAMA Neurol 79:1.130–1.138

Article  Google Scholar 

Gerard E (2023) Too much of a good thing? High-dose folic acid in pregnancy and childhood cancer. Epilepsy Curr 23:102–104

Article  PubMed  PubMed Central  Google Scholar 

Pennell PB, Karanam A, Meador KJ, Gerard E, Kalayjian L, Penovich P et al (2022) Antiseizure medication concentrations during pregnancy: results from the maternal outcomes and neurodevelopmental effects of antiepileptic drugs (MONEAD) study. JAMA Neurol 215487:

Lattanzi S, Trinka E, Del Giovane C, Nardone R, Silvestrini M, Brigo F (2019) Antiepileptic drug monotherapy for epilepsy in the elderly: a systematic review and network meta-analysis. Epilepsia 60:2.245–2.254

Article  Google Scholar 

Strzelczyk A, Schubert-Bast S (2022) Psychobehavioural and cognitive adverse events of anti-seizure medications for the treatment of developmental and epileptic encephalopathies. CNS Drugs 36:1.079–1.111

Article  Google Scholar 

Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R et al (2017) Cannabidiol in dravet syndrome study group. Trial of cannabidiol for drug-resistant seizures in the dravet syndrome. N Engl J Med 376:2.011–2.020

Article  Google Scholar 

Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M et al (2018) Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. N Engl J Med 378:1.888–1.897

Article  Google Scholar 

Thiele EA, Bebin EM, Bhathal H, Jansen FE, Kotulska K, Lawson JA et al (2021) Add-on Cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex: a placebo-controlled randomized clinical trial. JAMA Neurol 78:285–292

Article  PubMed